T560: an (H-2b x H-2a) F1 hybrid, phosphorylcholine (PC)-binding, murine B cell lymphoma that bears receptors for IgA and IgG, presents antigen and secretes IL-4.
We describe T560, a tissue culture-adapted B lymphoma derived from the gut-associated lymphoid tissue (GALT) of a (B10 x B10.H-2a H-4b)F1 hybrid mouse. This lymphoma is interesting and useful not only because it bears an unusual IgA receptor, fully described elsewhere, but also because it is potentially capable of presenting antigen to T cells restricted by the MHC of either parent. Here we document that T560 cells are IgG2a kappa +, Ia+, B220+, J11d.2+, CD3-, CD4-, CD5-, Mac 1-, Mac 2-, non-specific esterase-. They bind bromelain-treated mouse RBC (BrMRBC) in a PC chloride-inhibitable manner but do not bind SRBC, ox RBC (ORBC) or TNP-ORBC. Two lines, T560.1 and T560.2, and several clones are available. T560.1 and its clones contain low numbers of IgA rosette-forming cells (RFC), intermediate numbers of IgG2a RFC and moderately high numbers of IgG2b RFC; T560.2 and its clones contain moderately high numbers of IgA RFC and low numbers of both IgG2a and IgG2b RFC. Both lines stimulate both B10 and B10.A cells in mixed lymphocyte reactions (MLR) and present keyhole limpet hemocyanin (KLH) to KLH-reactive T cells. T560.2 populations are, however, more efficient possibly because they have somewhat higher proportions of brightly fluorescent Ia+ cells and secrete larger quantities of lymphokine than T560.1 cells. They present PC-conjugated KLH (PC-KLH) approximately 20 times more efficiently than unconjugated KLH, suggesting that their PC binding receptors function in antigen uptake. They constitutively produce IL-1, IL-4 and IL-6, but not IL-2, IL-5 or TGF beta. Neither their IgA nor their IgG receptor expression is affected by IL-4 or by IFNs-alpha, -beta, or -gamma. In their ability to bind BrMRBC and secrete IL-4, they resemble the CH12 lymphoma but differ from it in that they are of F1 hybrid origin, are CD5-, bear IgG2a rather than IgM, do not bind sheep erythrocytes and have a receptor for IgA not present on CH12.
Rao
T D
TD
Department of Pathology, New York University Medical Center, NY 10016.
Maghazachi
A A
AA
Faria
A M
AM
Basch
R S
RS
Phillips-Quagliata
J M
JM
D000818:Animals; D000943:Antigens, Differentiation / Q000096:biosynthesis*; D002460:Cell Line; D005434:Flow Cytometry; D007070:Immunoglobulin A / Q000276:immunology; D016130:Immunophenotyping; D015847:Interleukin-4 / Q000378:metabolism*; D007378:Interleukins / Q000032:analysis; D007959:Lymphocyte Culture Test, Mixed; D016393:Lymphoma, B-Cell / Q000276:immunology*; D051379:Mice; D011961:Receptors, Fc / Q000032:analysis / Q000096:biosynthesis*; D017452:Receptors, IgG; D011971:Receptors, Immunologic / Q000096:biosynthesis*; D012397:Rosette Formation; D015854:Up-Regulation
D000943:Antigens, Differentiation; C045281:IgA receptor; D007070:Immunoglobulin A; D007378:Interleukins; D011961:Receptors, Fc; D017452:Receptors, IgG; D011971:Receptors, Immunologic; D015847:Interleukin-4